Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment (2018)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.27322
Publication URI: https://www.repository.cam.ac.uk/handle/1810/279954
Type: Journal Article/Review